Marjorie Nelissen-Vrancken

Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate. The PROPER I-study

Klaas van der Spek, Debby L. Gerritsen, Martin Smalbrugge et al. · International Psychogeriatrics · 2016 · 71 citations · Full text

The effect of biannual medication reviews on the appropriateness of psychotropic drug use for neuropsychiatric symptoms in patients with dementia: a randomised controlled trial

Klaas van der Spek, Raymond T.C.M. Koopmans, Martin Smalbrugge et al. · Age and Ageing · 2018 · 45 citations · Full text

Can the PROPER intervention reduce psychotropic drug prescription in nursing home residents with dementia? Results of a cluster-randomized controlled trial

C.H.W. Smeets, Martin Smalbrugge, R.T.C.M. Koopmans et al. · International Psychogeriatrics · 2020 · 33 citations · Full text

Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals’ preferences

Marloes Dankers, Marjorie Nelissen-Vrancken, Bertien Hart et al. · Pharmacology Research & Perspectives · 2021 · 27 citations · Full text

Dutch Type 2, Medical Decision Making, Primary Care +17

PROPER I: frequency and appropriateness of psychotropic drugs use in nursing home patients and its associations: a study protocol

Klaas van der Spek, Debby L. Gerritsen, Martin Smalbrugge et al. · BMC Psychiatry · 2013 · 23 citations · Full text